131I has an intake retention fraction (IRF) of 0.133 and is detected in a nuclear technologist’s thyroid monitoring bioassay at the level of 0.11 ?Ci 24 hours after preparing doses of this isotope for a patient’s thyroid therapy. Does the technologist’s thyroid intake of 131I exceed 2 percent of the annual limits on intake (ALI) for this isotope? Is there a need for the radiation safety officer (RSO) to take any further action? Show your work!